164974
Compulsory HPV vaccination panel
Tuesday, November 6, 2007: 3:50 PM
Daniel A. Salmon, PhD, MPH
,
College of Medicine, University of Florida, Associate Professor of Epidemiology and Health Policy Research, Gainesville, FL
Texas is the first state to pass a law requiring Human Papillomavirus (HPV) vaccination for school attendance while many other states have similar laws under consideration. The Texas law was passed by the executive powers of the Governor rather than usual means for adding vaccines to those required for school, such as a change in the legislation or through a state vaccine advisory board. These other means for adding new vaccines to those required for school attendance include public input whereas in Texas the Governor made this decision unilaterally. A recent editorial in the New England Journal of Medicine (Colgrove, NEJM, Dec. 7, 2006) highlights the importance of giving proper consideration to the ethics and politics of compulsory vaccination for HPV vaccination. This panel discussion will highlight a variety of perspectives regarding making HPV vaccine mandatory. Panelists will provide a background of HPV and the newly available vaccine; review the history, strengths and limitations of compulsory vaccination laws; review ethical issues related to compulsory vaccination for HPV; present the Association of Immunization Managers policy on compulsory vaccination and the application of this policy framework to HPV vaccine; and present the perspective of the Family Research Council. Participation from the audience will be highly encouraged.
Learning Objectives: Provide background of HPV and the newly available vaccine
Review the history, strengths, and limitations of compulsory vaccination laws
Review ethical issues related to compulsory vaccination for HPV
Discuss a policy framework for compulsory vaccination and its application to HPV vaccine
Presenting author's disclosure statement:Any relevant financial relationships? Yes
Name of Organization |
Clinical/Research Area |
Type of relationship |
Merck |
vaccine |
Advisory Committee/Board |
Any institutionally-contracted trials related to this submission? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|